Clinical Trial: NCT05969314
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 1| Lead Sponsor: | Tata Memorial Hospital |
| Information Provided By: | Tata Memorial Hospital |
| Last Update Posted: | 2026-10-02 |
Study Overview
Brief Summary
Phase 1 study to assess the pharmacokinetic availability and safety and tolerability profile of one such ayurvedic preparation which contains 5 mg THC:CBD 1:1 preparation. Other than the PK profile, we will also be studying its effect on gene expression profiling of the breast and head neck oral cavity squamous cell carcinoma tissue.
Official Title
Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer
Conditions
Breast Cancer, Oral Cancer
Intervention / Treatment
- Drug: Cannabis capsules
Other Study ID Numbers
- TMH Project No. 3386
- CTRI/2020/06/020649
Start Date (Actual)
2022-06-08
Primary Completion Date (Estimated)
2026-12-30
Study Completion Date (Estimated)
2026-12-30
Enrollment (Actual)
12
Study Type
Interventional
Phase
Phase 1
| Lead Sponsor: | Tata Memorial Hospital |
| Information Provided By: | Tata Memorial Hospital |
| Last Update Posted: | 2026-10-02 |
Study Overview
Brief Summary
Phase 1 study to assess the pharmacokinetic availability and safety and tolerability profile of one such ayurvedic preparation which contains 5 mg THC:CBD 1:1 preparation. Other than the PK profile, we will also be studying its effect on gene expression profiling of the breast and head neck oral cavity squamous cell carcinoma tissue.
Official Title
Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer
Conditions
Breast Cancer, Oral Cancer
Intervention / Treatment
- Drug: Cannabis capsules
Other Study ID Numbers
- TMH Project No. 3386
- CTRI/2020/06/020649
Start Date (Actual)
2022-06-08
Primary Completion Date (Estimated)
2026-12-30
Study Completion Date (Estimated)
2026-12-30
Enrollment (Actual)
12
Study Type
Interventional
Phase
Phase 1